The world is changing. Medicine is changing. At The Ohio State University College of Medicine, we are leading the way.
The Ohio State University College of Medicine is known for curricular innovation, pioneering research and outstanding patient care at The Ohio State University Wexner Medical Center. With 2,000-plus faculty members, the college comprises 19 clinical departments, seven basic science departments and the School of Health and Rehabilitation Sciences.
“The only academic medical center in central Ohio is at the forefront of medicine” Click to tweet this story
Ohio State Wexner Medical Center, located in one of the most comprehensive health sciences campuses in America – with colleges of Medicine, Nursing, Pharmacy, Dentistry, Optometry, Public Health and Veterinary Medicine in close proximity – is part of The Ohio State University campus. This proximity fosters collaboration with other university departments, which makes Ohio State unique in its potential to promote scientific partnerships and the direct translation of research discoveries into new medical therapies and technologies. We offer dual-degree programs such as MD/MBA, MD/JD, MD/PhD and MD/MHA in collaboration with the Fisher College of Business, the College of Law and the College of Public Health.
The only academic medical center in central Ohio is at the forefront of medicine, where discovery and innovation in research laboratories make unique, effective therapies available to patients months, even years, before other hospitals. These initiatives are taking place within Ohio State's College of Medicine, more than a dozen affiliated research centers and seven hospitals.
The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute is a dedicated cancer hospital and research center. The OSUCCC – James is one of only 49 National Cancer Institute-designated comprehensive cancer centers and one of only a few centers conducting NCI-sponsored phase I and phase II clinical trials on novel anticancer agents.